Pharmacists in Chapel Hill, North Carolina


267 Pharmacists found in Chapel Hill
female pharmacist

Dr. Vineeta Rao, PHARMD, BCPS, CPP


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
101 Manning Dr, Chapel Hill, NC 27514
984-974-8346    

female pharmacist

Wendy C Cox, PHARMD


Pharmacist
101 Manning Dr, Chapel Hill, NC 27599
919-966-4996     919-843-5515

male pharmacist

Wesley Kufel


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
101 Manning Dr, Chapel Hill, NC 27514
315-657-6208    



male pharmacist

William Wilson, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
101 Manning Dr Bldg 1, Chapel Hill, NC 27514
913-314-8167    

male pharmacist

William Alan Murphy Jr., PHARMD


Pharmacist
301 Pharmacy Ln, Chapel Hill, NC 27599
919-966-5709    

male pharmacist

Wyt Ratanacharoensiri, PHARMD


Pharmacist
1500 E Franklin St, Chapel Hill, NC 27514
919-918-4392    

male pharmacist

Dr. Yousef Nabil Lafi, PHARMD



100 Eastowne Dr, Chapel Hill, NC 27514
984-974-7198    

male pharmacist

Dr. Yun Zhao, PH.D., PHARM.D.,


Pharmacist
311 Palafox Dr, Chapel Hill, NC 27516
919-968-0587    

male pharmacist

Zachariah M Deyo, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
101 Manning Dr, Cb 7600, Chapel Hill, NC 27514
919-966-2407     919-966-7163

male pharmacist

Dr. Zachary Tyler Tackett, PHARMD



301 Pharmacy Lane, Unc Eshelman School Of Pharmacy Cb # 7355, Chapel Hill, NC 27599
919-448-5804    

female pharmacist

Zaneera Hassan


Pharmacist
137 Forsyth Dr, Chapel Hill, NC 27517
703-864-3656    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.